Researchers detail how psoralen blocks signaling pathway of HER2-positive cancers

[News]

A common compound known to fight lymphoma and skin conditions actually has a second method of action that makes it particularly deadly against certain aggressive breast tumors, researchers at Duke Medicine report.

More... (http://www.news-medical.net/news/20140218/Researchers-detail-how-psoralen-blocks-signaling-pathway-of-HER2-positive-cancers.aspx)